Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Morgan Stanley from $20.00 to $25.00. They now have an "equal weight" rating on the stock.
Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030 | DelveInsight [Yahoo! Finance]
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? [Yahoo! Finance]
Phibro Animal Health Co. (NASDAQ: PAHC) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.